On Wednesday, Core Scientific earned an upgrade to its Relative Strength (RS) Rating, from 77 to 86.
Risk Management In The Stock Market: How Much Money To Invest Now
IBD's proprietary RS Rating measures technical performance by showing how a stock's price movement over the last 52 weeks measures up against that of the other stocks in our database.
History shows that the best stocks typically have an RS Rating north of 80 as they launch their biggest price moves.
Core Scientific is not currently near a potential buy zone. See if the stock goes on to build a sound pattern that could kick off a new price move.
While the company's top line growth fell last quarter from -33% to -56%, the bottom line grew 60%, up from 0% in the previous report.
The company earns the No. 38 rank among its peers in the Financial Services-Specialty industry group. X Financial ADR, Jiayin Group ADR and Nasdaq are among the top 5 highly rated stocks within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
IBD Stock Rating Upgrades: Rising Relative Strength
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
